Inactivation of the urdGT2 gene, which encodes a glycosyltransferase responsible for the C-glycosyltransfer of activated D-olivose, leads to formation of the novel urdamycins I, J, and K

Journal of the American Chemical Society

Volumn 121, Issue 48, 1999, Pages 11058-11062

  Künzel, Eva ^a   Faust, Bettina ^b   Oelkers, Carsten ^a   Weissbach, Ulrike ^a   Bearden, Daniel W ^c   Weitnauer, Gabriele ^b   Westrich, Lucia ^b   Bechthold, Andreas ^b   Rohr, Jürgen ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c CENTER FOR COASTAL ENVIRONMENTAL HEALTH AND BIOMOLECULAR RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOSYLTRANSFERASE; UNCLASSIFIED DRUG; URDAMYCIN I; URDAMYCIN J; URDAMYCIN K;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; GENE INACTIVATION; HUMAN; HUMAN CELL; NONHUMAN; STREPTOMYCES FRADIAE; STRUCTURE ANALYSIS;

EID: 0033537033     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja9915347     Document Type: Article

References (35)

1. Rohr, J.; Thiericke, R. Nat. Prod. Rep. 1992, 9, 103-137.
2. Krohn, K.; Rohr, J. Topics Curr. Chem. 1997, 188, 127-195.
3. Drautz, H.; Zähner, H.; Rohr, J.; Zeeck, A. J. Antibiot. 1986, 39, 1657-1669.
4. Chemically, the term "aglycon" is usually used to refer to the product obtained from acidic hydrolysis. This includes here the C-glycosidic moiety.
5. Rohr, J.; Beale, J. M.; Floss, H. G. J. Antibiot. 1989, 42, 1151-1157.
6. Rohr, J.; Schönewolf, M.; Udvarnoki, G.; Eckardt, K.; Schumann, G.; Wagner, C.; Beale, J. M.; Sorey, S. D. J. Org. Chem. 1993, 58, 2547-2551.
7. (a) Kulowski, K.; Wendt-Pienkowski, E.; Han, L.; Yang, K.; Vining, L. C.; Hutchinson, C. R. J. Am. Chem. Soc. 1999, 121, 1786-1794.
8. 7a
9. Decker, H.; Haag, S. J. Bacteriol. 1995, 177, 6126-6136.
10. Snipes, C. E.; Brillinger, G.-U.; Sellers, L.; Mascaro, L.; Floss, H. G. J. Biol. Chem. 1977, 252, 8113-8117.
11. Liu, H.-w.; Thorson, J. S. Annu. Rev. Microbiol. 1994, 48, 223-256.
12. Kirschning, A.; Bechthold, A.; Rohr, J. Topics Curr. Chem. 1997, 188, 1-84.
13. Russel, R. N.; Liu, H.-w. J. Am. Chem. Soc. 1991, 113, 7777-7778.
14. Draeger, G.; Park, S.-H.; Floss, H. G. J. Am. Chem. Soc. 1999, 121, 2611-2612.
15. Liu, S. Y.; Rosazza, J. P. N. Appl. Environ. Microbiol. 1998, 64, 3972-3976.
16. Decker, H.; Gaisser, S.; Pelzer, S.; Schneider, P.; Westlich, L.; Wohlleben, W.; Bechthold, A. FEMS Lett. 1996, 141, 195-201.
17. 18
18. Ichinose, K.; Bedford, D. J.; Tornus, D.; Bechthold, A.; Bibb, M. J.; Revill, W. P.; Floss, H. G.; Hopwood, D. A. Chem. Biol. 1998, 5, 647-659.
19. Westrich, L.; Domann, S.; Faust, B.; Bedford, D.; Hopwood, D. A.; Bechthold, A. FEMS Microbiol. Lett. 1999, 170, 381-387.
20. Quiros, L. M.; Aguirrezabalaga, I.; Olano, C.; Mendez, C.; Salas, J. A. Mol. Microbiol 1998, 28, 1177-1185.
21. Both compounds showed a strong positive NOE effect between 12a-OH and 4a-OH and a weaker one between 4a-OH and 12b-OH. 11 also shows an NOE effect between 12a-OH and 6a-H. The two coupling constants (5, 2 Hz) of 6a-H indicate its equatorial position. The sharpness of the tertiary 12a- and 12b-OH signals and the 2D-NOE spectra indicatees either a water molecule fixed between 12a-OH and 12b-OH through hydrogen bonds or a rapid exchange of the OH groups with residual water. The assumed conformations, i.e., ring A of 11 in twist boat, of 12 in half chair, and ring B in both compounds in chair conformation, are based on MM3* force field calculations.
22. Udvarnoki, G.; Henkel, T.; Machinek, R.; Rohr, J. J. Org. Chem. 1992, 57, 1274-1276.
23. Boyer, P. D.; Koeppe, O. J.; Luchsinger, W. W. J. Am. Chem. Soc. 1956, 78, 356-357.
24. Other observed upfield shifts: C-1 (Δδ 0.02 ppm); upfield shifts at C-7 and C-8 were not observable, due to the broadness of the signals or O-exchange with water, respectively.
25. (a) Weissbach, U.; Rohr, J., unpublished results.
26. (b) Weissbach, U., diploma thesis, University of Göttingen, Germany, 1997.
27. Irie, H.; Mizuno, Y.; Kuono, I.; Nagasawa, T.; Tani, Y.; Yamada, H.; Taga, T.; Osaki, K. J. Chem. Soc.. Chem. Commun. 1983, 174-175.
28. Nagasawa, T.; Fukao, H.; Irie, H.; Yamada, H. J. Antibiot. 1984, 41, 693-699.
29. Künzel, E.; Wohlert, S.-E.; Beninga, C.; Haag, S.; Decker, H.; Hutchinson, C. R.; Blanco, G.; Mendez, C.; Salas, J. A.; Rohr, J. Chem. Eur. J. 1997, 3, 1675-1678.
30. (a) Xue, Y. Q.; Wilson, D.; Zhao, L. S.; Liu, H. W.; Sherman, D. H. Chem. Biol. 1998, 5, 661-667.
31. (b) Zhao, L. S.; Sherman, D. H.; Liu, H. W. J. Am. Chem. Soc. 1998, 120, 10256-10257.
32. (a) Graziani, E. I.; Cane, D. E.; Betlach, M. C.; Kealy, J. T.; McDaniel, R. Bioorg. Med. Chem. Lett. 1998, 8, 3117-3120.
33. (b) Betlach, M. C.; Kealy, J. T.; Betlach, M. C.; Ashley, G. W.; McDaniel, R. Biochemistry 1998, 37, 14937-14942.
34. Sausville, E. A. National Cancer Institute, Bethesda, MD, personal communication. Here, the in vitro antitumor screen consisting of 60 human tumor cell lines was used. For further details, see http://dtp.nci.nih.gov.
35. Synthesized from 2-methylhydroquinone and maleic anhydride: Wallenfels, K. Ber. Dtsch. Chem. Ges. 1942, 75, 785.